Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2007; 13(2): 276-279
Published online Jan 14, 2007. doi: 10.3748/wjg.v13.i2.276
Published online Jan 14, 2007. doi: 10.3748/wjg.v13.i2.276
Table 1 Clinical characteristics of 48 patients undergoing ERCP
| Characteristic | Ciprofloxacin(n = 22) | None-ciprofloxacin(n = 26) | ||
| n | % | n | % | |
| Sex (M:F) | 13:9 | 59.1:40.9 | 11:15 | 42.3:57.7 |
| Age (mean ± SD yr) | 58.68 ± 13.7 | 61.08 ± 11.9 | ||
| Causes | ||||
| Bile duct stone | 7 | 31.8 | 15 | 57.7 |
| Cancer | 13 | 59.1 | 11 | 42.3 |
| Cholangiocarcinoma | 6 | 27.3 | 6 | 23.1 |
| Periampullary cancer | 6 | 27.3 | 5 | 19.2 |
| Hepatocellular cancer | 1 | 4.5 | 0 | 0 |
| Others | 2 | 9.1 | 3 | 11.54 |
| Bile duct stricture | 1 | 4.5 | 1 | 3.8 |
| Pseudocyst | 1 | 4.5 | 0 | 0 |
| Choledochal cyst | 0 | 0 | 1 | 3.8 |
| Chronicpancreatitis | 0 | 0 | 1 | 3.8 |
| Interventions | ||||
| Stone extraction | 5 | 22.7 | 13 | 50 |
| Sphincterotomy | 13 | 59.1 | 14 | 53.8 |
| Stent placement | 16 | 72.7 | 14 | 53.8 |
- Citation: Ratanachu-ek T, Prajanphanit P, Leelawat K, Chantawibul S, Panpimanmas S, Subwongcharoen S, Wannaprasert J. Role of ciprofloxacin in patients with cholestasis after endoscopic retrograde cholangiopancreatography. World J Gastroenterol 2007; 13(2): 276-279
- URL: https://www.wjgnet.com/1007-9327/full/v13/i2/276.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i2.276